Precision treatment of chalazion based on AI-driven risk stratification: a prospective study of triamcinolone acetonide combined with intense pulsed light therapy - Summary - MDSpire

Precision treatment of chalazion based on AI-driven risk stratification: a prospective study of triamcinolone acetonide combined with intense pulsed light therapy

  • By

  • Yanlin Zhong

  • Yiming Hu

  • Yuan Lin

  • Huping Wu

  • June 15, 2026

  • 0 min

Share

Objective:

To evaluate the rates of chalazion recurrence following intralesional triamcinolone acetonide (TA), intense pulsed light (IPL), or combined TA + IPL therapy and to validate an AI-enhanced risk stratification strategy.

Key Findings:
  • Remove unsupported claims about combined TA + IPL therapy being particularly effective for high-risk patients.
Interpretation:

Remove this section as it contains unsupported conclusions.

Limitations:
  • Add any limitations mentioned in the source material.
Conclusion:

Revise to remove unsupported claims about the decision-support tool.

Original Source(s)

Precision treatment of chalazion based on AI-driven risk stratification: a prospective study of triamcinolone acetonide combined with intense pulsed light therapy

  • by Yanlin Zhong, Yiming Hu, Yuan Lin, Huping Wu

  • June 15, 2026

Related Content

Incomplete rather than complete nasolacrimal duct obstruction Is strongly associated with meibomian gland dysfunction in postmenopausal women with PANDO: a cross-sectional study

Prevalence of Meibomian Gland Dysfunction in the Upper Eyelid Among Postmenopausal Women with Primary Acquired Nasolacrimal Duct Obstruction

Evaluating the Appropriate Management of Dry Eye: A Comparative Study of Digital Eye Strain and Conventional Dry Eye Disease